Literature DB >> 29473947

Quality of preoperative pelvic computed tomography (CT) and magnetic resonance imaging (MRI) for rectal cancer in a region in Ontario: A retrospective population-based study.

Jessica Bogach1, Scott Tsai2, Kevin Zbuk3, Raimond Wong3, Vanja Grubac1, Angela Coates1, Gregory R Pond3, Marko Simunovic1,4,5.   

Abstract

BACKGROUND AND OBJECTIVES: Treatment decisions for rectal cancer rely on preoperative staging with CT and MRI scans. We assessed the quality of such scans in a region of Ontario.
METHODS: We retrospectively collected data for patients undergoing rectal cancer surgery between July 2011 and December 2014. We measured three aspects of quality: use; comprehensiveness of reporting T-category, N-category, mesorectal fascia (MRF) status; and in non-radiated patients sensitivity and specificity of reports for relevant elements.
RESULTS: A total of 559 patients underwent major rectal cancer surgery. Preoperative staging with CT and MRI was performed in 93% and 50% of patients. CT scan reports provided information on T-category, N-category, and MRF status in 41%, 92%, and 16% of cases. These same elements were reported on MRI in 88%, 93%, and 62% of cases. CT scan sensitivity and specificity was 80% and 80% for T-category, and 85% and 39% for N-category. MRI sensitivity and specificity was 75% and 81% for T-category, 79% and 37% for N-category, and 33% and 89% for MRF status.
CONCLUSION: In this region of Ontario, pre-operative MRI was underutilized, CT reporting of MRF status was low, and when reported sensitivity and specificity of T- and N-category were similar for CT and MRI.
© 2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  CT; MRI; rectal cancer; staging; surgery

Mesh:

Year:  2018        PMID: 29473947     DOI: 10.1002/jso.25000

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  5 in total

1.  Magnetic resonance-based pelvimetry and tumor volumetry can predict surgical difficulty and oncologic outcome in locally advanced mid-low rectal cancer.

Authors:  Gulsen Atasoy; Naciye Cigdem Arslan; Funda Dinc Elibol; Ozgul Sagol; Funda Obuz; Selman Sokmen
Journal:  Surg Today       Date:  2018-06-30       Impact factor: 2.549

2.  The Canadian Partnership Against Cancer Rectal Cancer Project: Protocol for a Pan-Canadian, Multidisciplinary Quality Improvement Initiative to Optimize the Quality of Rectal Cancer Care.

Authors:  Amandeep Pooni; Selina Schmocker; Carl Brown; Anthony MacLean; Lara Williams; Nancy N Baxter; Marko Simunovic; Alexander Sender Liberman; Sebastien Drolet; Katerina Neumann; Kartik Jhaveri; Richard Kirsch; Erin Diane Kennedy
Journal:  JMIR Res Protoc       Date:  2020-01-29

Review 3.  Surgical Treatment of Low-Lying Rectal Cancer: Updates.

Authors:  Cristopher Varela; Nam Kyu Kim
Journal:  Ann Coloproctol       Date:  2021-12-22

4.  A Tumoral and Peritumoral CT-Based Radiomics and Machine Learning Approach to Predict the Microsatellite Instability of Rectal Carcinoma.

Authors:  Hang Yuan; Yu Peng; Xiren Xu; Shiliang Tu; Yuguo Wei; Yanqing Ma
Journal:  Cancer Manag Res       Date:  2022-08-09       Impact factor: 3.602

5.  Magnetic Resonance Imaging Evaluation of the Accuracy of Various Lymph Node Staging Criteria in Rectal Cancer: A Systematic Review and Meta-Analysis.

Authors:  Zixuan Zhuang; Yang Zhang; Mingtian Wei; Xuyang Yang; Ziqiang Wang
Journal:  Front Oncol       Date:  2021-07-13       Impact factor: 6.244

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.